MedPath
TGA Approval

WYOST denosumab 70mg/mL (120mg/1.7mL) solution for injection vial (418514)

418514

WYOST denosumab 70mg/mL (120mg/1.7mL) solution for injection vial

Sandoz Pty Ltd

August 23, 2024

Medicine

Medicine

Active

Registered

Active Ingredients

Denosumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

WYOST denosumab 70mg/mL (120mg/1.7mL) solution for injection vial (418514) - TGA 批准文号 | MedPath